National Guidelines «Acute Kidney Injury: Basic Principles of the Diagnosis, Prevention and Treatment (2015)» Part II
DOI:
https://doi.org/10.22141/2307-1257.3.17.2016.76539Abstract
The main problems of acute kidney injury (AKI) are considered. The necessity of introduction of the AKI concept into the practice of national health care is justified. Specific recommendations for the diagnosis, monitoring, prevention and treatment of this dangerous condition are
given.
Downloads
References
Добронравов В.А. Обзор патофизиологии острого повреждения почек // Острое повреждение почек / А.В. Смирнов, В.А. Добронравов, А.Ш. Румянцев, И.Г. Каюков. — М.: МИА, 2015. — 30-79.
Каюков И.Г., Смирнов А.В., Эмануэль В.Л. Цистатин С в современной медицине // Нефрология. — 2012. — 16(1). — 22-39.
Каюков И.Г., Смирнов А.В. Рентгеноконтрастная нефропатия // Нефрология: Национальное руководство / Под ред. Мухина Н.А. — М.: ГЭОТАР-Медиа, 2009. — 688-704.
Смирнов А.В. Клиника и диагностика острого повреждения почек // Острое повреждение почек / А.В. Смирнов, В.А. Добронравов, А.Ш. Румянцев, И.Г. Каюков. — М.: МИА, 2015. — 80-206.
Смирнов А.В. Клинические синдромы острого повреждения почек // Острое повреждение почек / А.В. Смирнов, В.А. Добронравов, А.Ш. Румянцев, И.Г. Каюков. — М.: МИА, 2015. — 207-304.
Смирнов А.В, Добронравов В.А., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии // Нефрология. — 2005. — 9(3). — 7-15.
Смирнов А.В., Каюков И.Г., Дегтерева О.А. и др. Проблемы диагностики и стратификации тяжести острого повреждения почек // Нефрология. — 2009. — 13(3). — 9-18.
Al-Ani A1., Al-Jalham K., Ibrahim T. et al. Factors determi-ning renal impairment in unilateral ureteral colic secondary to calcular disease: a prospective study // Int. Urol. Nephrol. — 2015. — 47(7). — 1085-1090.
Bagshaw S.M., Hoste E.A., Braam B., Briguori C., Kellum J.A., McCullough P.A., Ronco C. Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations // Contrib. Nephrol. — 2013. — 182. — 137-157.
Bainey K.R., Rahim S., Etherington K. et al. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial // Am. Heart J. — 2015. — 170(1). — 110-116.
Basi S., Pupim L.B., Simmons E.M. et al. Insulin resistance in critically ill patients with acute renal failure // Am. J. Physiol. Renal. Physiol. — 2005. — 289. — 259-264.
Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group // Crit. Care. — 2004. — 8. — 204-212.
Bellomo R., Cass A., Cole L. et al. Intensity of continuous renal replacement therapy in critically ill patients // N. Engl. J. Med. — 2009. — 361. — 1627-1638.
Bonventre J.V., Vaidya V.S., Schmouder R. et al. Next-ge-neration biomarkers for detecting kidney toxicity // Nat. Biotechnol. — 2010. — 28(5). — 436-440.
Bouman C., Kellum J.A., Levin N. Definition of acute renal failure. Acute Dialysis Quality Initiative. 2nd International Consensus Conference, 2002; National Kidney Foundation KD: Clinical practice guidelines for chronic Kidney disease: Evaluation, classification and stratification // Am. J. Kidney Dis. — 2002. — 39 [Suppl. 1]. — 1-266.
Bucaloiu I.D., Kirchner H.L., Norfolk E.R. et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury // Kidney Int. — 2012. — 81(5). — 477-485.
Case J., Khan S., Khalid R., Khan A. Epidemiology of acute kidney injury in the intensive care unit // Crit. Care Res. Pract. — 2013. — 479730. — doi: 10.1155/2013/479730. Epub 2013 Mar 21.
Casaer M.P., Mesotten D., Schetz M.R. Bench-to-bedside review: metabolism and nutrition // Crit. Care. — 2008. — 12(4). — 222.
Chowdhury A.H., Cox E.F., Francis S.T., Lobo D.N. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers // Annals of Surgery. — 2012. — 256(1). — 18-24.
Coca S.G., Singanamala S., Parikh C.R. Chronic kidney disease after acute kidney injury: a systematic review and metaanalysis // Kidney Int. — 2012. — 81(5). — 442-448.
Cogliati A.A., Vellutini R., Nardini A. et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study // J. Cardiothorac. Vasc. Anesth. — 2007. — 21. — 847-85.
Conti M., Moutereau S., Zater M. et al. Urinary cystatin C as a specifi c marker of tubular dysfunction // Clin. Chem. Lab. Med. — 2006. — 44(3). — 288-291.
Chertow G.M., Burdick E., Honour M. et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients // J. Am. Soc. Nephrol. — 2005. — 16. — 3365-3370.
Edelstein C.L. Biomarkers in Kidney Disease. — Elsevier Inc., 2011.
Ertmer C., Rehberg S., Van Aken H. et al. Relevance of non-albumin colloids in intensive care medicine // Best Pract. Res. Clin. Anaesthesiol. — 2009. — 23. — 193-212.
European Best Practice Guidelines for Haemodialysis (Part 1). V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system // Nephrol. Dial. Transplant. — 2002. — 17 (Suppl. 7). — 63-71.
Fiaccadori E., Regolisti G., Cabassi A. Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities // NDT Plus. — 2010. — 3(1). — 1-7.
Fiaccadori E., Regolisti G., Maggiore U. Specialized nutritional support interventions in critically ill patients on renal replacement therapy // Curr. Opin. Clin. Nutr. Metab. Care. — 2013. — 16(2). — 217-224.
Fouque D., Kalantar-Zadeh K., Kopple J. et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease // Kidney Int. — 2008. — 73(4). — 391-398.
Friedrich J.O., Adhikari N., Herridge M.S., Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death // Ann. Intern. Med. — 2005. — 142. — 510-524.
Fuiano G., Mazza G., Comi N. et al. Current indications for renal biopsy: a questionnaire-based survey // Am. J. Kidney Dis. — 2000. — 35(3). — 448-457.
Geus H., Betjes M., Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges // Clin. Kidney J. — 2012. — 5(2). — 102-108.
Giampietri C., Starace D., Petrungaro S., Filippini A., Ziparo E. Necroptosis: Molecular signalling and translational Implications // Int. J. Cell. Biol. — 2014. — 490275.
Gibney N.I., Hoste E., Burdmann E.A. et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions // Clin. J. Am. Soc. Nephrol. — 2008. — 3(3). — 876-880.
Haase M., Bellomo R., Haase-Fielitz A. Serum cystatin C may diagnose rather than predict acute kidney injury // Am. J. Kidney Dis. — 2012. — 59(4). — 582.
Haase N., Perner A., Hennings L.I. et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis // BMJ. — 2013. — 346. — f839.
Hirschberg R.I., Kopple J., Lipsett P. et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure // Kidney Int. — 1999. — 55(6). — 2423-2432.
Ho K.M., Power B.M. Benefits and risks of furosemide in acute kidney injury // Anaesthesia. — 2010. — 65(3). — 283-293.
Hoste E.A., Clermont G., Kersten A., Venkataraman R., Angus D.C., De Bacquer D., Kellum J.A. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis // Crit. Care. — 2006. — 10(3). — R73.
Jones J., Holmen J., De Graauw J. et al. Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality // Am. J. Kidney Dis. — 2012. — 60(3). — 402-408.
Hsu C.Y., McCulloch C.E., Fan D. et al. Community-based incidence of acute renal failure // Kidney Int. — 2007. — 72. — 208-212.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury // Kidney Int. — 2012. — Issue 1 Suppl. — 1-126.
Korkeila M., Ruokonen E., Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care // Intensive Care Med. — 2000. — 26. — 1824-1831.
Lewington A.J.P., Cerdá J., Mehta R.L. Raising awareness of Acute Kidney Injury: A global perspective of a silent killer // Kidney Int. — 2013. — 84(3). — 457-467.
Liano F., Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-basedstudy. Madrid Acute Renal Failure Study Group // Kidney Int. — 1996. — 50. — 811-818.
Lim W., Cook D.J., Crowther M.A. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials // J. Am. Soc. Nephrol. — 2004. — 15. — 3192-3206.
Lobo D.N., Stanga Z., Aloysius M.M. et al. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers // Critical Care Medicine. — 2010. — 38(2). — 464-470.
Lopez-Gomez J.M., Rivera F. Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis // Clin. J. Am. Soc. Nephrol. — 2008. — 3(3). — 674-681.
Macedo E., Bouchard J., Soroko S.H. et al. Fluidh accumulation, recognition and staging of acute kidney injury in critically-ill patients // Crit. Care. — 2010. — 14(3). — R82.
Mammen C., Al Abbas A., Skippen P. et al. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study // Am. J. Kidney Dis. — 2012. — 59(4). — 523-530.
Mårtensson J., Martling C.R., Bell M. Novel biomarkers of acute kidney injury and failure: clinical applicability // Br. J. Anaesth. — 2012. — 109(6). — 843-850.
Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., Levin A. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury // Crit. Care. — 2007. — 11(2). — R31.
Murugan R., Kellum J.A. // Nat. Rev. Nephrol. — 2011. — 7. — 209-217.
Noto A., Cibecchini F., Fanos V. et al. NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury // Biomed. Res. Int. — 2013. — id 612032.
Palevsky P.M., Zhang J.H., O’Connor T.Z. et al. Intensity of renal support in critically ill patients with acute kidney injury // N. Engl. J. Med. — 2008. — 359. — 7-20.
Patel K., King C.A., Jovin I.S. Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy aft er cardiac catheterization or percutaneous coronary intervention // Cardiovasc. Revasc. Med. — 2011. — 12. — 90-93.
Palevsky P.M., Liu K.D., Brophy P.D., Chawla L.S., Parikh C.R., Thakar C.V., Tolwani A.J., Waikar S.S., Weisbord S.D. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury // Am. J. Kidney Dis. — 2013. — 61(5). — 649-672.
Peng F., Su J., Lin J., Niu W. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis // J. Cardiovasc. Pharmacol. — 2015. — 65(3). — 262-268.
Piccinni P., Cruz D.N., Gramaticopolo S., Garzotto F., Dal Santo M., Aneloni G. et al. NE FROINT investigators. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT) // Minerva Anestesiol. — 2011. — 77. — 1072-1083.
Rivera F., Lopez-Gomez J.M., Perez-Garcia R. Clinicopathologic correlations of renal pathology in Spain // Kidney Int. — 2004. — 66(3). — 898-904.
Ronco C., Haapio M., House A.A., Anavekar N., Bellomo R.J. Cardiorenal syndrome // Am. Coll. Cardiol. — 2008. — 52(19). — 1527-1539.
Rosenzweig B., Pinthus J.H., Kleinmann N. et al. The relative contribution of urine extravasation to elevate plasma creatinine levels in acute unilateral ureteral obstruction // Can. Urol. Assoc. J. — 2015. — 9(7–8). — 428-433.
Salvadori M., Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations // World J. Nephrol. — 2013. — 2(3). — 56-76.
Scheinkestel C.D., Kar L., Marshall K. et al. Prospective randomized trial to assess caloric and protein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy // Nutrition. — 2003. — 19(11–12). — 909-916.
Shamir M.Y., Kaplan L., Marans R.S. et al. Urine fl ow is a novel hemodynamic monitoring tool for the detection of hypovolemia // Anesth. Analg. — 2011. — 112(3). — 593-596.
Slocum J.L., Heung M., Pennathur S. Marking renal injury: can we move beyond serum creatinine? // Transpl. Res. — 2012. — 159(4). — 277-289.
Sward K., Valsson F., Odencrants P. et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebocontrolled trial // Crit. Care Med. — 2004. — 32. — 1310-1315.
Tagawa M., Ogata A., Hamano T. Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study. — PLoS One, 2015, Jul 6. — 10(7). — e0132507. — doi: 10.1371.
Tesch G.H. Review: Serum and urine biomarkers of kidney disease: A pathophysiological perspective // Nephrology (Carlton). — 2010. — 15(6). — 609-616.
Thakar C.V., Christianson A., Almenoff P. et al. Degree of acute kidney injury before dialysis initiation and hospital mortality in critically ill patients // Int. J. Nephrol. — 2013. — 827459.
Umruddin Z., Moe K., Superdock K. ACE inhibitor or angiotensin II receptor blocker useis a risk factor for contrast-induced nephropathy // J. Nephrol. — 2012. — 25(5). — doi: 10.5301/jn.5000059.
Wiedermann C.J. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis // BMC Emerg. Med. — 2008. — 8. — 1-8.
Wu V.C., Wu C.H., Huang T.M. et al. Long-Term risk of coronary events after AKI // J. Am. Soc. Nephrol. — 6 February 2014. — doi: 10.1681/ASN.2013060610.
Waikar S.S., Liu K.D., Chertow G.M. Diagnosis, epidemiology and outcomes of acute kidney injury // Clin. J. Am. Soc. Nephrol. — 2008. — 3(3). — 844-861.
Waikar S.S., Bonventre J.V. Creatinine kinetics and the definition of acute kidney injury // J. Am. Soc. Nephrol. — 2009. — 20(3). — 672-679.
Wu P.C., Wu C.J., Lin C.J. et al. Long-term risk of upper gastrointestinal hemorrhage after advanced AKI // Clin. J. Am. Soc. Nephrol. — 2015. — 10(3). — 353-362.
Yang R.L., Wang X.T., Liu D.W., Liu S.B. Energy and oxygen metabolism disorder during septic acute kidney injury // Kidney Blood Press Res. — 2014. — 39(4). — 240-251.
Zeng X., McMahon G.M., Bates D.W., Waikar S.S. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals // Clin. J. Am. Soc. Nephrol. — 2014. — 9(1). — 12-20.
Zhang Z., Lu B., Sheng X. et al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis // Am. J. Kidney Dis. — 2011. — 58(3). — 356-365.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 A.V. Smirnov, V.A. Dobronravov
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 2307-1257
ISSN 2307-1265
